TVARDI THERAPEUTICS, INC. (TVRD) Free cash flow 2016–2024
TVARDI THERAPEUTICS, INC. (TVRD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$19.4MFY2024 · since FY2016: -$48.1M → -$19.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$19.4M | +79.5% |
| FY2023 | -$94.5M | -19.9% |
| FY2022 | -$78.8M | -31.0% |
| FY2021 | -$60.1M | -930.3% |
| FY2020 | -$5.8M | +94.7% |
| FY2019 | -$109.2M | -388.3% |
| FY2018 | -$22.4M | +59.2% |
| FY2017 | -$54.9M | -14.1% |
| FY2016 | -$48.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice